Cover Image
市場調查報告書

IMMD Inc. - 產品管線欄分析

IMMD Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 219737
出版日期 內容資訊 英文 23 Pages
訂單完成後即時交付
價格
Back to Top
IMMD Inc. - 產品管線欄分析 IMMD Inc. - Product Pipeline Review - 2015
出版日期: 2015年08月26日 內容資訊: 英文 23 Pages
簡介

IMMD Inc. 是由3個類別發展事業的藥物研發公司,從公司內部的藥物研發到外部的製藥公司,同時在各臨床階段藥物研發上進行與外部製藥公司的合作,更提供外部企業高品質的seed drug。

本報告提供IMMD Inc. 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

IMMD Inc.的基本資料

  • IMMD Inc.概要
  • 主要資訊
  • 企業資料

IMMD Inc. :R&D概要

  • 主要的治療範圍

IMMD Inc. :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

IMMD Inc. :開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

IMMD Inc. :藥物簡介

  • IMD-1041
  • IMD-0354
  • IMD-2560
  • IMD-4482
  • IMD-4852

IMMD Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

IMMD Inc. :暫停中的計劃

IMMD Inc. :總公司和子公司的所在地

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07456CDB

Summary

Global Markets Direct's, 'IMMD Inc. - Product Pipeline Review - 2015', provides an overview of the IMMD Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of IMMD Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of IMMD Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of IMMD Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the IMMD Inc.'s pipeline products

Reasons to buy

  • Evaluate IMMD Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of IMMD Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the IMMD Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of IMMD Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of IMMD Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of IMMD Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • IMMD Inc. Snapshot
    • IMMD Inc. Overview
    • Key Information
    • Key Facts
  • IMMD Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • IMMD Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • IMMD Inc. - Pipeline Products Glance
    • IMMD Inc. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • IMMD Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • IMMD Inc. - Drug Profiles
    • IMD-0354
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • IMD-2560
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • IMD-1041
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • IMD-4482
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • IMD-4852
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • IMMD Inc. - Pipeline Analysis
  • IMMD Inc. - Pipeline Products by Target
  • IMMD Inc. - Pipeline Products by Route of Administration
  • IMMD Inc. - Pipeline Products by Molecule Type
  • IMMD Inc. - Pipeline Products by Mechanism of Action
  • IMMD Inc. - Dormant Projects
  • IMMD Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • IMMD Inc., Key Information
  • IMMD Inc., Key Facts
  • IMMD Inc. - Pipeline by Indication, 2015
  • IMMD Inc. - Pipeline by Stage of Development, 2015
  • IMMD Inc. - Monotherapy Products in Pipeline, 2015
  • IMMD Inc. - Phase I, 2015
  • IMMD Inc. - Preclinical, 2015
  • IMMD Inc. - Pipeline by Target, 2015
  • IMMD Inc. - Pipeline by Route of Administration, 2015
  • IMMD Inc. - Pipeline by Molecule Type, 2015
  • IMMD Inc. - Pipeline Products by Mechanism of Action, 2015
  • IMMD Inc. - Dormant Developmental Projects,2015

List of Figures

  • IMMD Inc. - Pipeline by Top 10 Indication, 2015
  • IMMD Inc. - Pipeline by Stage of Development, 2015
  • IMMD Inc. - Monotherapy Products in Pipeline, 2015
  • IMMD Inc. - Pipeline by Top 10 Target, 2015
  • IMMD Inc. - Pipeline by Top 10 Route of Administration, 2015
  • IMMD Inc. - Pipeline by Top 10 Molecule Type, 2015
  • IMMD Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top